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Background: Recent studies suggested an important role for vascular factors in migraine etiopathogenesis. Notch4
belongs to a family of transmembrane receptors that play an important role in vascular development and
maintenance. The aim of this study was to test the hypothesis that polymorphisms of the NOTCH4 gene would
modify the occurrence and the clinical features of migraine.
Findings: Using a case–control strategy, we genotyped 239 migraine patients and 264 controls for three different
non-synonymous polymorphisms (T320A, G835V, R1346P) of the NOTCH4 gene and for the (CTG) n-encoding
polyleucine polymorphism in exon 1. Although the analyzed polymorphisms resulted not associated with migraine,
the clinical characteristics of our patients were significantly influenced by the different NOTCH4 genotypes. Longer
duration of disease and severity of neurovegetative symptoms during headache attacks were associated with the
R1346P and G835V polymorphisms, respectively. In female patients, worsening of migraine symptoms at menarche
was significantly correlated with T320A polymorphism.
Conclusions: Our study shows that genetic variations within the NOTCH4 gene significantly modify the clinical
characteristics of migraine and may have a role in disease pathogenesis.
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Migraine is a chronic and disabling neurovascular
disorder that affects approximately 15% of the general
population in Western Countries [1]. The diagnosis of
migraine, as proposed by the International Headache
Society (IHS), is mainly based on clinical features such as
unilateral throbbing headache, hypersensitivity to sound
and light, nausea and/or vomiting and focal neurological
symptoms (aura). According to these criteria, migraine is
classified into two main subtypes, migraine with aura
(MA) and migraine without aura (MO) [2].
Migraine etiology is complex and multifactorial, involving
both genetic and environmental factors that interact in a
manner yet to be completely understood. Mutations in
CACNA1A, ATP1A2 and SCN1A genes have been
associated with familial hemiplegic migraine (FHM), a
rare monogenic form of migraine [3]. Recently, mutations* Correspondence: elisa.rubino@unito.it
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have been linked to familial migraine with aura [4].
Genetic association studies and genome-wide association
studies (GWAS) suggested a role in migraine heritability
for a large number of different genes, highlighting the
genetic complexity of this disorder [5,6]. However, up to
now, no clear genetic association conferring major risk for
developing migraine has been found.
Although the pathophysiology of migraine is not
fully understood, cortical spreading depression (CSD), a
depolarization wave that propagates across the brain cortex
and activates the trigeminal nerve in animal models, is
speculated to cause the neurological symptoms typical of
migraine [7]. It has been suggested that CSD may be
initiated by a vascular event, implying that a vascular
endothelial dysfunction may increase migraine susceptibil-
ity [8]. Genetic studies provided evidence of an increased
susceptibility to migraine in patients with polymorphisms
in genes associated with endothelial function. The
endothelin type A receptor (ETA) gene −231 A/A poly-
morphism and the Angiotensin I-converting enzymean Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Demographic and clinical characteristics of
migraine patients
Migraine patients
Total Female Male
Total 239 165 74
Age (mean ± SD) 40.6 ± 13.0 40.7 ± 13.4 40.1 ± 11.9
Age at onset (mean ± SD) 18.1 ± 9.9 18.22 ± 10.1 17.8 ± 9.7
Duration of disease (yrs ± SD) 22.5 ± 13.5 22.6 ± 13.5 22.2 ± 13.6
Attacks/year 56.2 ± 57.9 52.9 ± 53.9 63.6 ± 65.8
Migraine without aura 190 130 60
Migraine with aura 49 30 19
Positive Familial History 184 137 47
Photophobia 192 137 55
Phonophobia 173 122 51
Nausea 184 134 50
Vomiting 121 91 30
Menstrual migraine 116 116 0
STAI-x1 40.4 ± 11.4 41.5 ± 11.6 37.9 ± 10.6
STAI-x2 44.2 ± 11.1 44.7 ± 11.2 43.2 ± 10.8
BDI 9.9 ± 7.9 10.4 ± 8.0 8.8 ± 7.6
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associated with migraine, both with and without aura
[9,10]. In addition, genes related to nitric oxide pathway
and vascular permeability (like VEGF) resulted significantly
associated with both migraine and aura [11].
NOTCH4 gene is located at 6p21.3, in the major
histocompatibility complex (MHC), a chromosomal
region intensively investigated in migraine [12,13]. The
gene encodes for a 2,003 amino acids long protein
involved in a cell-cell signalling pathway strongly conserved
during evolution. In situ hybridization revealed that
NOTCH4 transcripts are primarily restricted to endothelial
cells both in embryonic and adult life, suggesting a specific
role for Notch4 during vascular development [14]. Mice
mutants for the genes of the Notch system show important
defect in vascular morphogenesis [15]. In addition, Notch4
plays a crucial role in the differentiation of glial cells,
in the organization of neural processes [16] and in the
regulation of neural stem cells quiescence, activation,
and self-renewal [17].
Notch4 belongs to a family that in humans include
four receptors (Notch1-4), binding with different ligands,
such as Jagged1, Jagged2, Dll1 and Dll4 [15]. Mutations
in the Notch pathway genes, like NOTCH2 and JAG1,
are associated with Alagille syndrome, a multisystem
disorder that includes cardiac and vascular abnormalities
[18]. Mutations in NOTCH3 gene lead to a condition
named cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy (CADASIL)
that is associated with a higher prevalence of migraine
with aura [19].
The aim of the present work was to evaluate the
association between migraine and the NOTCH4 gene. We
studied several polymorphisms of the gene in a large cohort
of Italian migraine patients recruited from a University-
based Headache Center and in healthy controls.
Findings
Methods
Subjects
A group of 239 consecutive unrelated migraine patients
(165 females, 74 males; mean age ± SD = 40.6 ± 13.0 yrs),
recruited from the Headache Center of the University of
Torino (Italy), were selected for the study. The diagnosis
of migraine was made, according to the ICHD-II criteria
[2], by a neurologist specialized in headaches. One hundred
and ninety (79.5%) patients fulfilled the diagnostic criteria
for migraine without aura while forty nine patients (20.5%)
for migraine with aura. Mean age at onset and duration of
the disease were 18.1 ± 9.9 and 22.5 ± 13.5 yrs, respectively.
The patients underwent an extensive physical and neuro-
logical examination. All the clinical characteristics of the
patients were recorded using a standardized questionnaire.
Psychological evaluation was performed by a psychologistwith the use the Beck Depression Inventory (BDI) and the
State and Trait Anxiety Inventory (STAI x-1 and STAI x-2)
tests. Table 1 summarizes the demographic and clinical
characteristics of migraine patients. A group of 264 age and
sex matched healthy subjects (169 females, 95 males, mean
age ± SD = 41.6 ± 12.8 yrs) was used as control. The
controls were blood donors and were screened to exclude
primary headaches. Both patients and controls were of
Caucasian origin. Written informed consent was obtained
from all participants and the study was approved by the
local Ethics Committee. The same population was previ-
ously used to perform genetic association studies between
DNA polymorphisms and migraine [20,21].
DNA extraction and genotyping
We examined three non synonymous polymorphisms
(T320A - rs422951, G835V - rs9267835, and R1346P -
rs8192573) and the (CTG) n-encoding polyleucine
polymorphism in exon 1 for NOTCH4 gene. All poly-
morphisms, selected from SNPs database of NCBI
(www.ncbi.nlm.nih.gov/), are located in regions of putative
functional relevance.
Genomic DNA was extracted from 200 μl of periph-
eral blood using the QIAamp DNA mini Kit (QIAGEN).
PCR reactions were performed with 90 ng of genomic
DNA, 0.4 unit of Taq Gold DNA polymerase, 250 nM of
each primer, 1.5 mM MgCl2 and 50 mM dNTPs. For
non synonymous polymorphisms, PCR conditions used
were: an initial denaturation at 95°C 10 min followed by
35 cycles 95°C for 1 min, annealing specific temperature
Table 2 Genotype and Allele Frequencies of the NOTCH4 polymorphisms in migraine patients and controls
N GF AF
NOTCH4 T320A A>G A/A (%) A/G (%) G/G (%) A (%) G (%)
- Migraine patients 239 40 (16.7) 140 (58.6) 59 (24.7) 220 (46.0) 258 (54.0)
- Controls 264 67 (25.4) 127 (48.1) 70 (26.5) 260 (49.4) 268 (50.6)
NOTCH4 G835V G>T G/G (%) G/T (%) T/T (%) G (%) T (%)
- Migraine patients 239 231 (96.6) 8 (3.4) 0 (0.0) 470 (98.3) 8 (1.7)
- Controls 264 256 (97.0) 8 (3.0) 0 (0.0) 520 (98.5) 8 (1.5)
NOTCH4 R1346P G>C G/G (%) G/C (%) C/C (%) G (%) C (%)
- Migraine patients 239 223 (93.3) 16 (6.7) 0 (0.0) 462 (96.7) 16 (3.3)
- Controls 264 244 (92.4) 19 (7.2) 1 (0.4) 507 (96.0) 20 (4.0)
N= number of subjects, GF = genotypic frequency, AF = allelic frequency.
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1 min with a final extension at 72°C for 5 min. PCR
products were electrophoresed on a 2% agarose TBE 1X
gel and stained with ethidium bromide. All non syn-
onymous polymorphisms were analyzed by enzymatic
digestion. Genotyping for T320A, G835V, R1346P poly-
morphisms was performed by digesting PCR products
with BsuRI, XmiI, SmaI restriction enzyme, respectively.
Conversely, (CTG)n polymorphism was performed on
ABI 3700 sequencer (Applied Biosystems, Inc); PCR
product was obtained using the same mixture previously
described and using the following primers: forward:
5- CCTGCCTGAAGAGGGACAG-3, reverse: 5-CCCCA
CTGATCATCCTCCTA-3. The forward primer was
fluorescently labeled with FAM. Alleles were scored
using GeneMarker v1.5 software package (SoftGenetics
LLC – www.softgenetics.com).
Statistics
Fisher’s exact test, χ2 test and Monte Carlo Markov
chain method (MCMC), were used to compare allelic
(AF) and genotypic frequencies (GF) between cases and
controls. Patients clinical characteristics were analyzed
with ANOVA followed by Bonferroni correction for
multiple comparisons. Statistical analysis was performed
using Statistical Package for Social Sciences – version 20
(IBM SPSS Statistics 20.0 - August 2011 - SPSS Inc.,
Chicago Ill). The Hardy-Weinberg equilibrium was verified
for observed genotype frequency in all tested populations
in order to detect deviation from the expected genotypeTable 3 Allelic frequencies of the polymorphic CTG repeat in
6R (%) 7R (%) 8R (%) 9R (%
Migraine patients 43 (9.00) 1 (0.21) 3 (0.63) 156 (
Controls 53 (10.04) 0 (0.00) 0 (0.00) 167 (distribution and to detect genotyping errors. The level of
statistical significance was taken at p<0.05.
Results
Table 2 shows genotypic (GF) and allelic (AF) frequencies
of the three non-synonymous coding sequence variants
(T320A, G835V, R1346P) of the NOTCH4 gene in
migraineurs and controls. GF and AF of the examined
polymorphisms were not significantly different between
cases and controls. Subsequently, we analyzed the recessive,
dominant and additive models for different alleles without
reaching any statistical difference.
Table 3 shows allelic frequencies of the (CTG) n-encoding
polyleucine polymorphism in cases and controls. No
significant difference was found between the two groups.
When we divided the migraine patients into different
subgroups (MA and MO, episodic and chronic migraine),
according to IHCD-II criteria, no significant difference in
the distribution of the genetic variants was found.
Finally, we compared the clinical characteristics (age
of onset, duration of the disease, frequency of migraine
as attacks for year, photophobia, phonophobia, nausea,
vomiting, menstrual migraine, and variation at menarche)
of our migraine patients according to different NOTCH4
genotypes. Interestingly, we found that the carriage of the
allele T of the G835V polymorphism was associated with
a higher frequency of vomiting (p=0,034), while carrying
the allele C of R1346P polymorphism correlated with a
longer duration of disease (p=0,020). When we analyzed
our patients according to gender, we found that in femalesexon 1 of the NOTCH4 gene
Alleles
) 10R (%) 11R (%) 12R (%) 13R (%)
32.64) 116 (24.27) 112 (23.43) 27 (5.65) 20 (4.18)
31.63) 140 (26.52) 118 (22.35) 40 (7.58) 10 (1.89)
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T320A and worsening of symptoms at menarche (p=0,016).
When patients were divided into migraine with aura and
without aura subgroups, no significant difference was found.
Discussion
To the best of our knowledge, this is the first study that
investigated the association between migraine and the
NOTCH4 gene. We found that the analyzed polymor-
phisms are not significantly associated with the disease.
Genotypic and allelic frequencies of the examined poly-
morphisms were similarly distributed between cases and
controls. When patients were divided into migraine with
aura and without aura subgroups, no significant difference
was found. It is unlikely that genetic variations within the
NOTCH4 gene contribute greatly to migraine susceptibil-
ity. In addition, we assessed the relation between different
NOTCH4 genotypes and the clinical characteristics of
migraine. Intriguingly, we found that several characteristics
of the disease, like the presence of neurovegetative
symptoms, the duration of the disease and the worsening
of symptoms at menarche were influenced by NOTCH4
genotypes. Our data support a role for NOTCH4 as a
disease-modifier gene in migraine.
There are some limitations in our study that deserve
mention and suggest caution in the interpretation of the
results. First of all, we performed our study in a sample
of patients recruited from an Headache Center that may
not be representative of the general migraine population
[22]. In addition, the number of migraine with aura patients
genotyped in our study may be too low for subgroups
analysis. Finally, it is well known that results of genetic
association studies must be viewed cautiously until they
are confirmed by multiple replications studies [23,24].
Our data are in accordance with several studies suggesting
a significant involvement of vascular mechanisms in mi-
graine etiopathogenesis. First of all, migraine symptoms are
included in the phenotype of several genetic vasculopathies
like cerebral autosomal dominant arteriopathy with subcor-
tical infarcts and leucoencephalopathy (CADASIL), retinal
vasculopathy with cerebral leukodystrophy (RVCL) and
hereditary infantile hemiparesis, retinal arteriolar tortuosity
and leukoencephalopahty (HIHRATL) [25]. It is of interest
to note that all the aforementioned disorders are mainly
characterized by involvement of small vessels in the brain.
Secondly, it is well known that several vascular genetic
risk factors, like the methylenetetrahydrofolate reductase
(MTHFR) gene and angiotensin I-converting enzyme
(ACE) genes, are significantly associated with migraine
[26,27]. Finally, epidemiological studies have linked
migraine with and without aura to a broader range of
ischemic vascular disorders including angina, myocardial
infarction, coronary revascularization, claudication and
cardiovascular mortality [28].How genetic and acquired vascular mechanisms might
be involved in migraine pathogenesis is still matter of
investigation. A dysfunction in endothelial function has
been suggested as a key finding in migraine pathogenesis.
The endothelium regulates numerous vascular functions. In
response to specific stimuli, endothelial cells secrete local
vasoactive mediators, including the vasodilator nitric oxide
(NO) and vasoconstrictor endothelin-1 (ET-1) and tissue-
type plasminogen activator (t-PA). Several observations
suggest that endothelial function is abnormal in migraine
patients, including an increased prevalence of anti-
endothelial cell antibodies that may induce endothelial
damage and raised plasma levels of ET-1 and von
Willebrand factor [29]. Finally, endothelial progenitor
cells were shown to be significantly reduced in migraine
patients [30]. An increasing understanding of the role of
endothelium dysfunction in migraine pathogenesis may
suggest new strategy for disease treatment.
In conclusion, we found no evidence for a strong
association between the NOTCH4 gene and migraine and
our data does not support the hypothesis that the
NOTCH4 gene is a major genetic risk factor for migraine.
However, due to the relatively small number of subjects
examined, replication studies in larger samples are required
in order to confirm our data. Intriguingly, we found that
genetic variants within NOTCH4, a gene involved in vascu-
lar maintenance and remodeling, significantly influence
several clinical features of migraine. Our results further
support a role for vascular genetic factor in the disease.
Finally, we can hypothesize that the NOTCH4 gene may be
particularly involved in some migraine subtypes. Additional
studies in families segregating an atypical migraine
phenotype are warranted to test this hypothesis.
Competing interest
The authors declare that they have no conflicting interest.
Authors’ contributions
ER and IR conceived and supervised the project and drafted the manuscript.
PDM, MLG, SG, and SG were responsible for migraineurs patient collection.
PF and SB carried out the molecular genetic studies. FG and AV performed
the statistical analyses. LP edited the manuscript for intellectual content. All
authors read and approved the final manuscript.
Acknowledgements
The study was supported by grants from the “Ministero dell’Istruzione,
dell’Università e della Ricerca (MIUR)” and from Regione Piemonte (Italy).
Received: 17 December 2012 Accepted: 17 December 2012
Published: 26 March 2013
References
1. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF (2002)
Migraine in the United States: epidemiology and patterns of health care
use. Neurology 58(6):885–894
2. Headache Classification Subcommittee of the International Headache
Society (2004) The international classification of headache disorders: 2nd
edn. Cephalalgia 24(1):1–151
3. Schürks M (2012) Genetics of migraine in the age of genome-wide
association studies. J Headache Pain 13(1):1–9
Rubino et al. The Journal of Headache and Pain 2013, 14:28 Page 5 of 5
http://www.thejournalofheadacheandpain.com/content/14/1/284. Lafrenière RG, Cader MZ, Poulin JF, Andres-Enguix I, Simoneau M, Gupta N,
Boisvert K, Lafrenière F, McLaughlan S, Dubé MP, Marcinkiewicz MM,
Ramagopalan S, Ansorge O, Brais B, Sequeiros J, Pereira-Monteiro JM,
Griffiths LR, Tucker SJ, Ebers G, Rouleau GA (2010) A dominant-negative
mutation in the TRESK potassium channel is linked to familial migraine with
aura. Nat Med 16(10):1157–1160
5. Rudkjobing LA, Esserlind AL, Olesen J (2012) Future possibilities in migraine
genetics. J Headache Pain 13(7):505–11
6. Di Lorenzo C, Grieco GS, Santorelli FM (2012) Migraine headache: a
review of the molecular genetics of a common disorder. J Headache
Pain 13(7):571–80
7. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz M (2002)
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine
model. Nat Med 8:136–142
8. Parsons AA, Strijbos PJ (2003) The neuronal versus vascular hypothesis of
migraine and cortical spreading depression. Curr Opin Pharmacol 3:73–77
9. Tzourio C, El Amrani M, Poirier O, Nicaud V, Bousser MG, Alperovitch A
(2001) Association between migraine and endothelin type A receptor
(ETA −231 A/G) gene polymorphism. Neurology 56(2):1273–7
10. Kowa H, Fusayasu E, Ijiri T, Ishizaki K, Yasui K, Nakaso K, Kusumi M,
Takeshima T, Nakashima K (2005) Association of the insertion/deletion
polymorphism of the angio- tensin I-converting enzyme gene in patients of
migraine with aura. Neurosci Lett 374(2):129–31
11. Gonçalves FM, Luizon MR, Speciali JG (2012) Haplotypes in candidate genes
related to nitric oxide pathway and vascular permeability associated with
migraine and aura. J Headache Pain 13(4):335–6
12. Martelletti P, Lulli P, Morellini M, Mariani B, Pennesi G, Cappellacci S, Brioli G,
Giacovazzo M, Trabace S (1999) Chromosome 6p-encoded HLA-DR2
determination discriminates migraine without aura from migraine with aura.
Hum Immunol 60(1):69–74
13. Rainero I, Grimaldi LM, Salani G, Valfre W, Rivoiro C, Savi L, Pinessi L (2004)
Association between the tumor necrosis factor-alpha −308 G/A gene
polymorphism and migraine. Neurology 62(1):141–143
14. Roca C, Adams RH (2007) Regulation of vascular morphogenesis by Notch
signaling. Genes Dev 21(20):2511–2524
15. Krebs LT, Xue Y, Norton CR (2000) Notch signaling is essential for vascular
morphogenesis in mice. Genes Dev 14(11):1343–1352
16. Harper JA, Yuan JS, Tan JB, Visan I, Guidos CJ (2003) Notch signaling in
development and disease. Clin Genet 64(6):461–472
17. Ables JL, Breunig JJ, Eisch AJ, Rakic P (2011) Not(ch) just development:
Notch signalling in the adult brain. Nat Rev Neurosci 12(5):269–283
18. Turnpenny PD, Ellard S (2012) Alagille syndrome: pathogenesis, diagnosis
and management. Eur J Hum Genet 20(3):251–257
19. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P,
Alamowitch S, Domenga V, Cécillion M, Marechal E, Maciazek J,
Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach
JF, Bousser MG, Tournier-Lasserve E (1996) Notch3 mutations in
CADASIL, a hereditary adult-onset condition causing stroke and
dementia. Nature 383(6602):707–710
20. Rainero I, Pinessi L, Salani G, Valfrè W, Rivoiro C, Savi L, Gentile S, Lo Giudice
R, Grimaldi L (2002) A polymorphism in the interleukin-1alpha gene
influences the clinical features of migraine. Headache 42:337–340
21. Rainero I, Salani G, Valfré W, Savi L, Rivoiro C, Ferrero M, Pinessi L, Grimaldi
LM (2003) Absence of linkage between the interleukin-6 gene (−174 G/C)
polymorphism and migraine. Neurosci Lett 343(3):155–158
22. Ziegler DK, Paolo AM (1996) Self-reported disability due to headache: a
comparison of clinic patients and controls. Headache 36(8):476–480
23. Bird TD, Jarvik GP, Wood NW (2001) Genetic association studies: genes in
search of diseases. Neurology 57(7):1153–1154
24. Marian AJ (2012) Molecular genetic studies of complex phenotypes. Transl
Res 159(2):64–79
25. Stam AH, Haan J, van den Maagdenberg AM, Ferrari MD, Terwindt GM (2009)
Migraine and genetic and acquired vasculopathies. Cephalalgia 29(9):1006–17
26. Rubino E, Ferrero M, Rainero I, Binello E, Vaula G, Pinessi L (2009)
Association of the C677T Polymorphism in the MTHFR Gene with Migraine:
a Meta-Analysis. Cephalalgia 29(8):818–825
27. Schürks M, Rist PM, Kurth T (2010) MTHFR 677C>T and ACE D/I polymorphisms
in migraine: a systematic review and meta-analysis. Headache 50(4):588–599
28. Sacco S, Ricci S, Carolei A (2012) Migraine and vascular diseases: a review of
the evidence and potential implication for management. Cephalalgia
32(10):785–79529. Hamed SA, Hamed EA, Ezz Eldin AM, Mahmoud NM (2010) Vascular risk
factors, endothelial function, and carotid thickness in patients with
migraine: relationship to migraine. J Stroke Cerebrovasc Dis 19(2):92–103
30. Rodríguez-Osorio X, Sobrino T, Brea D, Martínez F, Castillo J, Leira R (2012)
Endothelial progenitor cells: a new key for endothelial dysfunction in
migraine. Neurology 79(5):474–479
doi:10.1186/1129-2377-14-28
Cite this article as: Rubino et al.: Genetic variants in the NOTCH4 gene
influence the clinical features of migraine. The Journal of Headache and
Pain 2013 14:28.Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
